Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Deutsche Bank
German global banking and financial services company
-
Stifel
American investment bank
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- HighPeak Energy, Inc. was listed on the Nasdaq electronic stock exchange and received buy/sell ratings from analysts on May 26, 2026.
- Goldman Sachs and Deutsche Bank both set high stock market targets on November 3, 2026.
- Assembly Biosciences stock traded on Nasdaq, while UBS cut its price target but maintained a Buy rating, following an SEC disclosure.
- Shopify stock trading on Nasdaq was accompanied by new analyst coverage, including a rating downgrade from Morgan Stanley.
- Rating firms Bank of America and Cantor Fitzgerald raised price targets and upgraded the rating for Seagate Technology (STX) stock, which trades on the Nasdaq exchange.